💊 Dasatib 70 mg Tablet | Dasatinib | Oncology Therapy | Export Supplier
Dasatib 70 mg Tablet contains Dasatinib, a tyrosine kinase inhibitor used in the treatment of certain leukemias. It works by blocking abnormal proteins that promote cancer cell growth under medical supervision.
🔹 Product Category
Oncology Medicine (Targeted Therapy)
🔹 Composition
Dasatinib 70 mg
🔹 Indications
✔ Chronic Myeloid Leukemia (CML)
✔ Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
🔹 Key Benefits
✔ Targeted anti-cancer therapy
✔ Inhibits abnormal cell proliferation
✔ Oral administration for convenience
✔ Widely used in hematology protocols
🔹 Dosage & Administration
✔ Oral tablet
✔ Strictly as prescribed by oncologist
✔ Dose based on disease stage and response
🔹 Regulatory & Safety Notice
✔ Prescription-only medicine
✔ Requires careful monitoring during treatment
✔ Export compliance documentation required
🔹 Packaging
✔ Tablet / Blister Packaging
✔ Export-Ready Packaging Available
✔ Bulk Supply Supported
🔹 Certifications
✔ WHO-GMP Certified
✔ COA & COPP Available
🌍 Target Export Markets & Cities
🇺🇸 USA: New York, Chicago, Houston
🇬🇧 UK: London, Manchester
🇦🇪 UAE: Dubai, Abu Dhabi
🇸🇬 Singapore: Singapore
🇮🇳 India: Mumbai, Delhi, Bangalore
🇵🇭 Philippines: Manila
🇻🇳 Vietnam: Ho Chi Minh City, Hanoi
🇿🇦 South Africa: Johannesburg, Cape Town
🇳🇬 Nigeria: Lagos, Abuja
🇰🇪 Kenya: Nairobi
🇧🇷 Brazil: São Paulo
🇲🇽 Mexico: Mexico City
🇵🇪 Peru: Lima
📍 Location: Nagpur, Maharashtra, India
📦 Product Catalogue Available
✔ Oncology Medicines
✔ Hematology Treatments
✔ Targeted Cancer Therapies
📞 Instant Support – Call / WhatsApp Now
📲 +91 8007161282
📲 +91 9970011496
📧 Email
✉️ sales@pacificmedicines.com
 Tablet In USA, UK, Canada Australia, UAE, Saudi Arabia South Africa, Singapore){kind=link}